𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The future of small molecule inhibitors in lymphoma

✍ Scribed by John Gerecitano


Publisher
Current Science Inc.
Year
2009
Tongue
English
Weight
242 KB
Volume
11
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development of anaplastic lymphoma kinas
✍ Rongshi Li; Stephan W. Morris πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion formsβ€”the most common being nucleophosmin (NPM)‐ALKβ€”in a non‐Hodgkin's lymphoma (N

Small Molecule Inhibitors of Plasma Kall
✍ Wendy B. Young; Roopa Rai; William D. Shrader; Jana Burgess-Henry; Huiyong Hu; K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 2 views
Non-peptidic Small Molecule Inhibitors o
✍ Cheol-Min Park; Chaohong Sun; Edward T. Olejniczak; Alan E. Wilson; Robert P. Me πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons βš– 26 KB πŸ‘ 2 views